Australia markets open in 5 hours 38 minutes

Oscar Health, Inc. (OSCR)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
15.56+0.76 (+5.14%)
As of 02:22PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 3.40B
Enterprise value 1.83B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.56
Price/book (mrq)4.23
Enterprise value/revenue 0.31
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.78
52-week change 3136.80%
S&P500 52-week change 321.83%
52-week high 318.55
52-week low 34.72
50-day moving average 315.09
200-day moving average 39.43

Share statistics

Avg vol (3-month) 33.14M
Avg vol (10-day) 32.12M
Shares outstanding 5194.21M
Implied shares outstanding 6229.73M
Float 8171.1M
% held by insiders 11.79%
% held by institutions 180.16%
Shares short (28 Mar 2024) 46.95M
Short ratio (28 Mar 2024) 42.38
Short % of float (28 Mar 2024) 44.24%
Short % of shares outstanding (28 Mar 2024) 43.02%
Shares short (prior month 29 Feb 2024) 45.44M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023


Profit margin -4.62%
Operating margin (ttm)-10.20%

Management effectiveness

Return on assets (ttm)-3.62%
Return on equity (ttm)-31.86%

Income statement

Revenue (ttm)5.86B
Revenue per share (ttm)26.44
Quarterly revenue growth (yoy)41.80%
Gross profit (ttm)N/A
EBITDA -204.92M
Net income avi to common (ttm)-270.73M
Diluted EPS (ttm)-1.22
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.56B
Total cash per share (mrq)11.16
Total debt (mrq)379.76M
Total debt/equity (mrq)47.11%
Current ratio (mrq)1.26
Book value per share (mrq)3.51

Cash flow statement

Operating cash flow (ttm)-272.16M
Levered free cash flow (ttm)546.01M